
New York: Monthly Obesity Injection Promises Major Weight Loss, Study Finds
Read Time:43 Second
A promising new drug called MariTide shows potential for significant weight loss with just one injection per month. In a recent phase 2 clinical trial, participants taking MariTide lost about 20% of their body weight over the course of one year.
Key Benefits of MariTide
- Monthly Injection: Offers a more convenient alternative to current weekly weight-loss treatments.
- Substantial Weight Loss: Participants experienced approximately 20% reduction in body weight.
- Improved Patient Adherence: Fewer injections could lead to better compliance with treatment protocols.
Future Outlook
The trial results bring hope to millions struggling with obesity by presenting a simpler and effective solution. Researchers plan to continue studies to confirm both the safety and long-term effects of MariTide. The medical community is closely monitoring further developments related to this drug.
For the latest updates on MariTide and other medical advancements, stay tuned to Questiqa USA.

Average Rating